Symbol="SRPT"
AssetType="Common Stock"
Name="Sarepta Therapeutics Inc"
Description="Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="873303"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="11195333000"
EBITDA="-460492000"
PERatio="None"
PEGRatio="159.25"
BookValue="7.95"
DividendPerShare="0"
DividendYield="0"
EPS="-10.26"
RevenuePerShareTTM="11.39"
ProfitMargin="-0.905"
OperatingMarginTTM="-0.502"
ReturnOnAssetsTTM="-0.103"
ReturnOnEquityTTM="-1.237"
RevenueTTM="1003434000"
GrossProfitTTM="-78066000"
DilutedEPSTTM="-10.26"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.119"
AnalystTargetPrice="178.74"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="12.49"
PriceToBookRatio="25.74"
EVToRevenue="12.09"
EVToEBITDA="-17.47"
Beta="0.979"
num_52WeekHigh="159.89"
num_52WeekLow="100.15"
num_50DayMovingAverage="110.79"
num_200DayMovingAverage="123.44"
SharesOutstanding="93149000"
DividendDate="None"
ExDividendDate="None"
symbol="SRPT"
open="118.90"
high="121.22"
low="118.63"
price="120.02"
volume="610044.00"
latest_trading_day="2023-08-29"
previous_close="118.60"
change="1.42"
change_percent="1.1973%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="53"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="47"
Volume_recent_avg="1318452"
Change_recent_avg="-0.23"
Delta_recent_avg="3.97"
Variance_recent_avg="1.99"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="47"
Aroon_momentum_negative="53"
image_negative_thumbnail_id_1="1148"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0181.jpeg"
image_negative_thumbnail_id_2="1086"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0119.jpeg"
image_neutral_thumbnail_id_1="524"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_neutral_thumbnail_id_2="579"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0020.jpeg"
image_positive_thumbnail_id_1="688"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_positive_thumbnail_id_2="610"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0098.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
